高级检索
当前位置: 首页 > 详情页

Sinomenine protects mice against ischemia reperfusion induced renal injury by attenuating inflammatory response and tubular cell apoptosis

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Changhai Hospital, Second Military Medical University, Shanghai 200003, China [2]Institute of Organ Transplantation, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China [3]National Key Laboratory of Medical Immunology and Department of Immunology, Second Military Medical University, Shanghai 200433, China [4]The Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
出处:
ISSN:

关键词: Sinomenine reperfusion injury inflammation apoptosis

摘要:
Sinomenine (SIN) is a purified alkaloid from the Chinese herb Sinomenium acutum. Previous studies demonstrated that SIN possesses anti-inflammatory and anti-apoptotic properties. We thus in the present report conducted studies to examine its impact on ischemia reperfusion (IR) induced renal injury. Precondition of mice with 200 mg/ kg of SIN provided significant protection for mice against IR-induced renal injury as manifested by the attenuated serum creatinine (Cre) and blood urea nitrogen (BUN) along with less severity for histological changes and tubular cell apoptosis. In line with these results, treatment of mice with SIN suppressed IR-induced inflammatory infiltration and the expression of chemokine CXCL-10, adhesion molecule ICAM-1, and cytokines TNF-a/IL-6. Mechanistic studies revealed that SIN inhibits NF-kappa B transcriptional activity to suppress IR-induced inflammatory response in the kidney, while it attenuates MAP kinase signaling to prevent tubular cells undergoing apoptosis after IR insult. Altogether, our data support that SIN could be a useful therapeutic agent for prevention and treatment of IR-induced renal injury in the clinical settings.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
JCR分区:
出版当年[2011]版:
Q2 PATHOLOGY Q3 ONCOLOGY
最新[2023]版:
Q3 PATHOLOGY Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者单位: [1]Changhai Hospital, Second Military Medical University, Shanghai 200003, China
共同第一作者:
通讯作者:
通讯机构: [2]Institute of Organ Transplantation, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China [3]National Key Laboratory of Medical Immunology and Department of Immunology, Second Military Medical University, Shanghai 200433, China [*1]National Key Laboratory of Medical Immunology and Department of Immunology, Second Military Medical University, 800 Xiangyin Rd, Shanghai 200433, China. [*2]Institute of Organ Transplantation, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)